CG Oncology (CGON) Receivables (2023 - 2026)
CG Oncology posted quarterly Receivables of $1.3 million for Q1 2026, up 269.57% year-on-year from $345000.0 in Q1 2025, and up 85.32% on a QoQ basis from $688000.0 in Q4 2025.
CG Oncology (CGON) has 4 years of Receivables data on file, last reported at $1.3 million in Q1 2026.
- For the quarter ending Q1 2026, Receivables rose 269.57% year-over-year to $1.3 million; the trailing twelve-month figure through Mar 2026 stood at $1.3 million (up 269.57% YoY), and the FY2025 full-year result was $688000.0, changed N/A from the prior year.
- Receivables for Q1 2026 stood at $1.3 million, up from $688000.0 in the prior quarter.
- Across five years, Receivables topped out at $1.3 million in Q1 2026 and bottomed at $92000.0 in Q4 2023.
- The 4-year median for Receivables is $345000.0 (2025), against an average of $438777.8.
- Peak annual rise in Receivables reached 275.91% in 2025, while the deepest fall reached 125.49% in 2025.
- A 4-year view of Receivables shows it stood at $92000.0 in 2023, then surged by 48.91% to $137000.0 in 2024, then soared by 402.19% to $688000.0 in 2025, then surged by 85.32% to $1.3 million in 2026.
- The last three Receivables figures came in at $1.3 million (Q1 2026), $688000.0 (Q4 2025), and $515000.0 (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | 13.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | 4.15 Mn |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 2.00 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 5.73 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 883.96 Mn |
| 10 | CG Oncology | 5.01 Bn | 5.01 Bn | -1.88 Mn | 1.28 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1.28 Mn |
| Dec 31, 2025 | 688,000.00 |
| Sep 30, 2025 | 515,000.00 |
| Jun 30, 2025 | 562,000.00 |
| Mar 31, 2025 | 345,000.00 |
| Sep 30, 2024 | 137,000.00 |
| Jun 30, 2024 | 182,000.00 |
| Mar 31, 2024 | 153,000.00 |
| Dec 31, 2023 | 92,000.00 |